Application Note: Individualized Cancer Diagnostics - Mutation Detection of EGF Receptor and KRAS Gene
2 December 2017

The future of cancer treatment is thought to be through personalised therapies, such as the treatment of non-small-cell-lung-cancer with tyrosine kinase inhibitors. This application note demonstrates the use of the Implen NanoPhotmeter P-Series for DNA quantification in personalized cancer therapies.

Company